DaVita HealthCare Partners Aktie
147,54USD | 0,90USD | 0,61% |
WKN: 897914 / ISIN: US23918K1088
Aktionärsstruktur
Inhaber | in % |
---|---|
Freefloat | 95,51 |
Berkshire Hathaway, Inc. | 44,02 |
Berkshire Hathaway, Inc. (Investment Management) | 44,02 |
The Vanguard Group, Inc. | 7,71 |
Vanguard Group, Inc. (Subfiler) | 6,30 |
State Street Corp. | 2,94 |
Ted R Weschler | 2,66 |
BlackRock Fund Advisors | 2,32 |
Government Pension Fund - Global (The) | 1,91 |
Vanguard Total Stock Market ETF | 1,62 |
Vanguard 500 Index Fund | 1,49 |
BlackRock Institutional Trust Co. NA | 1,49 |
Geode Capital Management LLC | 1,42 |
LSV Asset Management | 1,29 |
Vanguard Small Cap Index Fund | 1,28 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 65 000 | 67 000 | 69 000 | 70 000 | 70 000 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,18 | 0,17 | 0,17 | 0,17 | 0,17 |
Bilanz (in Mio. USD) - Aktiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 3 690 | 3 149 | 3 168 | 3 155 | 3 138 |
Summe Anlagevermögen | 14 388 | 14 613 | 14 703 | 14 524 | 14 482 |
Summe Aktiva | 18 078 | 17 762 | 17 871 | 17 680 | 17 619 |
Bilanz (in Mio. USD) - Passiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Fremdkapital | 14 578 | 14 865 | 15 500 | 15 455 | 14 876 |
Summe Eigenkapital | 3 500 | 2 897 | 2 371 | 2 225 | 2 743 |
Summe Passiva | 18 078 | 17 762 | 17 871 | 17 680 | 17 619 |
Adresse
2000 16th Street, 80202-7198 Denver | |
Telefon | +1 (720) 631-2100 |
Internet | http://www.davita.com |
Management
Adam H. Schechter
Independent Director |
Alan Cullop
Chief Information Officer |
Andrew Mohraz
Associate General Counsel & Head-Investigations |
Barbara Jean Desoer
Independent Non-Executive Director |
Bruce E. Ware
Vice President |
Charles G. Berg
Independent Director |
Christopher M. Berry
Chief Accounting Officer |
David P. Maughan
Chief Operating Officer |
Dennis W. Pullin
Independent Director |
Gregory J. Moore
Independent Director |
James O. Hearty
Chief Compliance Officer |
Jason M. Hollar
Independent Director |
Javier J. Rodriguez
Chief Executive Officer & Director |
Jeffrey A. Giullian
Chief Medical Officer-Kidney Care |
Jeffrey Wagner
Senior Vice President |
Jessica Hergenreter
Chief People Officer |
Joel Ackerman
Chief Financial Officer & Treasurer |
Kathleen Alyce Waters
Chief Legal & Public Affairs Officer |
Madhu Narasimhan
Chief Information Officer |
Mahesh Krishnan
Group Vice President-Growth |
Michael D. Staffieri
Chief Operating Officer-Emeritus |
Nic Eliason
Investor Relations Contact |
Pamela M. Arway
Independent Chairman |
Phyllis R. Yale
Independent Non-Executive Director |
Samantha A. Caldwell
Secretary |
Wendy Lee Schoppert
Independent Director |